Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
221
-
Total 13F shares, excl. options
-
54M
-
Shares change
-
+8.76M
-
Total reported value, excl. options
-
$1.6B
-
Value change
-
+$264M
-
Put/Call ratio
-
0.36
-
Number of buys
-
125
-
Number of sells
-
-57
-
Price
-
$29.58
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q2 2020
258 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q2 2020.
Editas Medicine, Inc. - Common Stock (EDIT) has 221 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54M shares
of 82.8M outstanding shares and own 65.3% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (7.55M shares), VANGUARD GROUP INC (5.76M shares), Sumitomo Mitsui Trust Holdings, Inc. (5M shares), Nikko Asset Management Americas, Inc. (4.99M shares), BlackRock Inc. (4.99M shares), STATE STREET CORP (3.08M shares), Capital World Investors (1.76M shares), FEDERATED HERMES, INC. (1.7M shares), CAAS CAPITAL MANAGEMENT LP (1.4M shares), and D. E. Shaw & Co., Inc. (1.28M shares).
This table shows the top 221 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.